{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:39:03Z","timestamp":1784335143324,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.xphs.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T06:24:12Z","timestamp":1599373452000},"page":"397-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC\/D3 Cells Via the Proton-Coupled Organic Cation Antiporter"],"prefix":"10.1016","volume":"110","author":[{"given":"Yuma","family":"Tega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetsugu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuta","family":"Oshitari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2020.09.001_bib1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","article-title":"Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development","volume":"24","author":"Ohtsuki","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2020.09.001_bib2","series-title":"Drug Delivery to the Brain. Physiological Concepts, Methodologies, and Approaches","first-page":"23","article-title":"Recent progress in blood-brain barrier and blood-CSF barrier transport research: pharmaceutical relevance for drug delivery to the brain","author":"Tachikawa","year":"2014"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.001_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-8118-10-8","article-title":"Functional expression of a proton-coupled organic cation (H+\/OC) antiporter in human brain capillary endothelial cell line hCMEC\/D3, a human blood-brain barrier model","volume":"10","author":"Shimomura","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.001_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2020.09.001_bib5","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1002\/jps.24129","article-title":"Transport characteristics of tramadol in the blood-brain barrier","volume":"103","author":"Kitamura","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1248\/bpb.b13-00773","article-title":"Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC\/D3","volume":"37","author":"Okura","year":"2014","journal-title":"Biol Pharm Bull"},{"issue":"17","key":"10.1016\/j.xphs.2020.09.001_bib7","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.lfs.2007.01.035","article-title":"Blood-brain barrier transport of pramipexole, a dopamine D2 agonist","volume":"80","author":"Okura","year":"2007","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dmpk.2014.12.006","article-title":"Memantine transport by a proton-coupled organic cation antiporter in hCMEC\/D3 cells, an in\u00a0vitro human blood-brain barrier model","volume":"30","author":"Higuchi","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuint.2012.11.014","article-title":"Blood-to-brain influx transport of nicotine at the rat blood\u2013brain barrier: involvement of a pyrilamine-sensitive organic cation transport process","volume":"62","author":"Tega","year":"2013","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.001_bib10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.xphs.2017.04.032","article-title":"Involvement of proteon-coupled organic cation antiporter in varenicline transport at blood-brain barrier of rats and in human brain capillary endothelial cells","volume":"106","author":"Kurosawa","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.001_bib11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/jcbfm.2009.54","article-title":"Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs","volume":"29","author":"Andr\u00e9","year":"2009","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.001_bib12","doi-asserted-by":"crossref","first-page":"pyu001","DOI":"10.1093\/ijnp\/pyu001","article-title":"Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability","volume":"18","author":"Chapy","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2020.09.001_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/bdd.707","article-title":"Involvement of an influx transporter in the blood-brain barrier transport of naloxone","volume":"31","author":"Suzuki","year":"2010","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.001_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/bdd.2014","article-title":"Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine","volume":"37","author":"Suzuki","year":"2016","journal-title":"Biopharm Drug Dispos"},{"issue":"20","key":"10.1016\/j.xphs.2020.09.001_bib15","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1111\/bph.13258","article-title":"Pharmacophore-based discovery of inhibitors of a novel drug\/proton antiporter in human brain endothelial hCMEC\/D3 cell line","volume":"172","author":"Chapy","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.001_bib16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/acsmedchemlett.8b00099","article-title":"Design, synthesis, and blood-brain barrier transport study of pyrilamine analogs as histone deacetylase inhibitors","volume":"9","author":"Hiranaka","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.xphs.2020.09.001_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2017.03.034","article-title":"Pyrilamine-sensitive proton-coupled organic cation (H+\/OC) antiporter for brain-specific drug delivery","volume":"254","author":"Wang","year":"2017","journal-title":"J\u00a0Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.001_bib18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1124\/dmd.105.007898","article-title":"A\u00a0pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism","volume":"34","author":"Au-Yeung","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2020.09.001_bib19","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1002\/jps.22567","article-title":"Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in\u00a0vitro and in\u00a0vivo","volume":"100","author":"Sadiq","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jps.24691","article-title":"Cocktail-dosing microdialysis study to simultaneously assess delivery of multiple organic-cationic drugs to the brain","volume":"105","author":"Kitamura","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0167-4889(87)90136-4","article-title":"Regulation of intracellular pH in LLC-PK1 cells studied using 31P-NMR spectroscopy","volume":"927","author":"Jans","year":"1987","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.001_bib22","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1124\/dmd.106.010876","article-title":"Molecular identification and functional characterization of rat multidrug and toxin extrusion type transporter 1 as an organic cation\/H+ antiporter in the kidney","volume":"34","author":"Ohta","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.xphs.2020.09.001_bib23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A\u00a0pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J\u00a0Pharmacobiodyn"},{"issue":"6","key":"10.1016\/j.xphs.2020.09.001_bib24","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1177\/0271678X16662042","article-title":"Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: application to [11C]diphenhydramine positron emission tomography imaging","volume":"37","author":"Auvity","year":"2017","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.001_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2014.01.078","article-title":"Ascorbate reverses high glucose- and RAGE-induced leak of the endothelial permeability barrier","volume":"445","author":"Meredith","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.xphs.2020.09.001_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1023\/A:1018923017954","article-title":"Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures","volume":"11","author":"Yamazaki","year":"1994","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2020.09.001_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2012","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"10.1016\/j.xphs.2020.09.001_bib28","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/jcbfm.2015.160","article-title":"Mechanism of brain targeting by dexibuprofen prodrugs modified with ethanolamine-related structures","volume":"35","author":"Li","year":"2015","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"24","key":"10.1016\/j.xphs.2020.09.001_bib29","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1021\/jm501100b","article-title":"Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals","volume":"57","author":"Vitaku","year":"2014","journal-title":"J\u00a0Med Chem"},{"issue":"2","key":"10.1016\/j.xphs.2020.09.001_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/med.21634","article-title":"Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules","volume":"40","author":"Kourounakis","year":"2020","journal-title":"Med Res Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920304949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920304949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:30:35Z","timestamp":1758360635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920304949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0022354920304949"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.001","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC\/D3 Cells Via the Proton-Coupled Organic Cation Antiporter","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}